Song wins John D. Thompson Prize for Young Investigators
Muss Receives ASCO’s Allen S. Lichter Visionary Leader Award for improving cancer care in older adultsRead More
AACR honors Spears for longstanding advocacy on behalf of cancer patients
Henderson, Rivera awarded $1.5 million lung cancer screening study grantDaniel Richardson joins Hematology/Oncology Faculty
We are pleased to announce that Daniel Richardson joined the Leukemia and Lymphoma Group in the Division of Hematology Oncology as an Assistant Professor August 1, 2020. Dr. Richardson first joined the Cancer Outcomes Research Program as a fellow in the Division of Hematology/Oncolgoy. Prior to coming to UNC, he completed medical school and residency at The Ohio State University following a Masters in Philosophy of Religion and Ethics at Biola University. In conjunction with a clinical career in leukemia, his research focuses on health services and cancer outcomes including developing novel tools to quantify patient preferences, understand the experience of older patients with cancer, and improving physician well-being. His work also explores ethical issues within oncology surrounding the physician-patient relationship and the financial consequences of cancer care. His free time is often spent enjoying NC with his family.
Lisa Spees joins Health Policy and Management faculty
We are very excited to announce that Lisa Spees will be joining the department of Health Policy and Management in the Gillings School of Public Health as an Assistant Professor starting July 2020. Dr. Spees first joined the CORP as post-doctoral researcher in the Cancer Care Quality Training Program. She is interested in examining and reducing health disparities by improving cancer care quality and access among minority and rural populations. To date, her research in this area has focused on identifying multi-level (patient, provider, and organizational) barriers across the cancer care continuum. Her current projects include examining the financial impact of receiving a hematopoietic stem cell transplant among pediatric cancer patients, identifying barriers to oral anticancer agents utilization and adherence among patients with renal cell carcinoma, and improving access to guideline-concordant care for patients with gynecologic malignancies.
Shekinah Elmore joins Radiation Oncology faculty
We are very excited to announce that Shekinah Elmore joined the department of Radiation Oncology in the School of Medicine as an Assistant Professor starting August 2020. Dr. Elmore comes to UNC from the Harvard Radiation Oncology Residency Program in Boston. During her time at Harvard, Dr. Elmore received a Fulbright grant to work with Partners in Health in Rwanda to explore the patient experience of cancer care. During her residency, she focused on understanding and improving radiotherapy access in resource-limited settings and promoting pathways for resident involvement in improving global radiotherapy. A cancer survivor herself, she has written and spoke about her personal experience treading the line between cancer patient and provider, including a TEDMED talk in 2020 about the importance of embracing compassionate care and coping with uncertainty. She splits her time between treating patients in the clinic and conducting global health and healthcare equity research. Her clinical expertise is in the treatment of patients with breast and genitourinary cancers.